Publications Rotterdam Study
2004
Alizadeh BZ, Njajou OT, Houwing-Duistermaat JJ, Jong G de, Vergeer JM, Hofman A, Pols HAP, Duijn CM van. Does bilirubin project against hemochromatosis gene (HFE) related mortality? Am J Med Gen 2004;129A:39-43.
Bakker SL, Leeuw FE de, Heijer T den, Koudstaal PJ, Hofman A, Breteler MM. Cerebral haemodynamics in the elderly: the Rotterdam Study. Neuroepidemiology 2004;23:178-84. Bleumink GS, Duijn CM van, Kingma JH, Witteman JCM, Hofman A, Stricker BHCh. Apolipoprotein E ε4 allele is associated with left ventricular systolic dysfunction. Am Heart J 2004;147:685-9.
Bleumink GS, Deinum J, Mosterd A, Witteman JC, Hofman A, Stricker BH. Antihypertensive treatment is associated with improved left ventricular geometry: the Rotterdam Study. Pharmacoepidemiol Drug Saf 2004;13:703-9.
Bleumink GS, Knetsch AM, Sturkenboom MC, Straus SM, Hofman A, Deckers JW,
Witteman JC, Stricker BH. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure in the Rotterdam Study. Eur Heart J
2004;25:1614-9.
Bleumink GS, Rietveld I, Janssen JAMJL, Rossum EFC van, Deckers JW, Hofman A, Witteman JCM, Duijn CM van, Stricker BHCh. Insulin-like growth factor-I gene polymorphism and risk of heart failure (the Rotterdam Study).
Am J Cardiol 2004;94:384-6.
Dijk EJ van, Vermeer SE, Groot JC de, Minkelis J van de, Prins ND, Oudkerk M, Hofman A, Koudstaal PJ, Breteler MMB. Arterial oxygen saturation, COPD, and cerebral small vessel disease. J Neurol Neurosurg Psychiatry 2004;75:733-6.
Dijk EJ van, Breteler MM, Schmidt R, Berger K, Nilsson LG, Oudkerk M, Pajak A, Sans S, Ridder M, Dufouil C, Fuhrer R, Giampaoli S, Launer LJ, Hofman A; CASCADE Consortium. The association between blood pressure, hypertension, and cerebral white matter lesions: cardiovascular determinants of dementia study. Hypertension 2004;44:625-30.
Dijk EJ van, Prins ND, Vermeer SE, Hofman A, Duijn CM van, Koudstaal PJ, Breteler MMB. Plasma amyloid β, apolipoprotein E, lacunar infarcts, and white matter lesions. Ann Neurol 2004;55:570-5.
Engelhart MJ, Geerlings MI, Meijer J, Kiliaan A, Ruitenberg A, Swieten JC van, Stijnen T, Hofman A, Witteman JC, Breteler MM. Inflammatory proteins in plasma and the risk of dementia: the Rotterdam Study. Arch Neurol 2004;61:668-72.
Engelhart MJ, Ruitenberg A, Meijer J, Kiliaan A, Swieten JC van, Hofman A, Witteman JC, Breteler MM. Plasma levels of antioxidants are not associated with Alzheimer’s disease or cognitive decline. Dement Geriatr Cogn Disord 2004;19:134-9.
Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, Meer IM van der, Hofman A, Witteman JC. Dietary intake of menoquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr 2004;134:3100-5.
Goderie-Plomp HW, Klift M van der, Ronde W de, Hofman A, Jong FH de, Pols HA.
Endogenous sex hormones, sex hormone-binding globulin, and the risk of incident vertebral fractures in elderly men and women: the Rotterdam study. J Clin Endocrinol Metab
Hak AE, Witteman JCM, Hugens W, Keyzer JJ, Pop VJ, Uitterlinden AG, Pols HAP. The increase of cholesterol with menopause is associated with the apolipoprotein E genotype. A population-based longitudinal study. Atherosclerosis 2004;174:169-76.
Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, Stampfer M. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004;35:1584-8.
Heijer T den, Vermeer SE, Dijk EJ van, Prins ND, Koudstaal PJ, Duijn CM van, Hofman A, Breteler MM. Alcohol intake in relation to brain magnetic resonance imaging findings in older persons without dementia. Am J Clin Nutr 2004;80:992-7.
Heijer T den, Schuit SCE, Pols HAP, Meurs JBJ van, Hofman A, Koudstaal PJ, Duijn CM van, Uitterlinden AG, Breteler MMB. Variations in estrogen receptor α gene and risk of dementia, and brain volumes on MRI. Mol Psychiatry 2004;9:1129-35.
Ikram MK, Jong FJ de, Vingerling JR, Witteman JC, Hofman A, Breteler MM, Jong PT de. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004;45:2129-34.
Jong PTVM de. Risk profiles for ageing macular disease. Ophthalmologica 2004;218: Suppl 1: 5-16.
Klift M van der, Laet CE de, McCloskey EV, Johnell O, Kanis JA, Hofman A, Pols HA. Risk factors for incident vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 2004;19:1172-80.
Lau LM de, Giesbergen PC, Rijk MC de, Hofman A, Koudstaal PJ, Breteler MM. Incidence of parkinsonism and Parkinson disease in a general population: the Rotterdam Study.
Neurology 2004;63:1240-4.
Kors JA, Rijnbeek P, Herpen G van, Keulers PP, Hofman A, Witteman JC. Spatial
repolarization parameters for predicting cardiac death in the elderly. J Electrocardiol 2004;37 Suppl:198-200.
Leebeek FW, Meer IM van der, Witteman JC. Genetic variability of von Willebrand factor and atherosclerosis. Circulation. 2004;110:e57.
Leeuw FE de, Richard F, Groot JC de, Duijn CM van, Hofman A, Gijn J van, Breteler MM. Interaction between hypertension, apoE and cerebral white matter lesions. Stroke
2004;35:1057-60.
Leeuwen R van, Klaver CC, Vingerling JR, Hofman A, Duijn CM van, Stricker BH, Jong PT de. Cholesterol and age-related macular degeneration: is there a link? Am J Ophthalmol 2004;137:750-2.
Leeuwen R van, Tomany SC, Wang JJ, Klein R, Mitchell P, Hofman A, Klein BEK, Vingerling JR, Cumming RG, Jong PTVM de. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. Ophthalmology
2004;111:1169-75.
Maitland-van der Zee AH, Klungel OH, Stricker BHCh, Veenstra DL, Kastelein JJP, Hofman A, Witteman JCM, Leufekens HGM, Duijn CM van, Boer A de. Pharmacoeconomic
evaluation of testing for angiotensin-converting enzyme genotype before starting [beta]-hydroxy-[beta]-methylglutaryl coenzyme A reductase inhibitor therapy in men.
Pharmacogenetics 2004;14:53-60.
Maitland-van der Zee AH, Klungel OH, Stricker BHCh, Verschuren WMM, Witteman JCM, Stijnen T, Hofman A, Breteler MMB, Leufkens GM, Boer A de. Comparison of two
methodologies to analyze exposure to statins in an observational study on effectiveness. J Clin Epidemiol 2004;57:237-42.
Maitland-van der Zee AH, Stricker BH, Klungel OH, Kastelein JJ, Hofman A, Witteman JC, Leufkens HG, Duijn CM van, Boer AA de. Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism. Atherosclerosis 2004;175:377-9. Mattace-Raso FU, Cammen TJ van der, Sayed-Tabatabaei FA, Popele NM van, Asmar R, Schalekamp MA, Hofman A, Duijn CM van, Witteman JC. Angiotensin-converting enzyme gene polymorphism and common carotid stiffness: the Rotterdam Study. Atherosclerosis 2004;174:121-6.
Mattace-Raso FUS, Cammen TJM van der, Meer IM van der, Schalekamp MADH, Asmar R, Hofman A, Witteman JCM. C-reactive protein and arterial stiffness in older adults: the Rotterdam Study. Atherosclerosis 2004;176:111-6.
Mattace-Raso FUS, Cammen TJM van der, Popele NM van, Kuip DAM van der,
Schalekamp MADH, Hofman A, Breteler MMB, Witteman JCM. Blood pressure components and cardiovascular events in older adults: the Rotterdam Study. J Am Geriatr Soc
2004;52:1538-42.
Meer IM van der, Bots ML, Hofman A, del Sol AI, Kuip DA van der, Witteman JC. Predictive value of noninvasive measures of atherosclerosis for incident myocardial infarction: the Rotterdam Study. Circulation 2004;109:1089-94.
Meer IM van der, Brouwers GJ, Bulk S, Leebeek FW, Kuip DA van der, Hofman A, Witteman JC, Gomez Garcia EB. Genetic variability of von Willebrand factor and risk of coronary heart disease: the Rotterdam Study. Br J Haematol 2004;124:343-7.
Meer IM van der, Witteman JC, Hofman A, Kluft C, Maat MP de. Genetic variation in
Fcgamma receptor IIa projects against advanced peripheral atherosclerosis. The Rotterdam Study. Thromb Haemost 2004;92:1273-6.
Meurs JB van, Dhonukshe-Rutten RA, Pluijm SM, Klift M van der, Jonge R de, Lindemans J, Groot LC de, Hofman A, Witteman JC, Leeuwen JP van, Breteler MM, Lips P, Pols HA, Uitterlinden AG. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004;350:2033-41.
Nouwen JL, Ott A, Kluytmans-Vandenbergh MF, Boelens HA, Hofman A, Belkum A van, Verbrugh HA. Predicting the staphylococcus aureus nasal carrier state: derivation and validation of a ‘culture rule’. Clin Infect Dis 2004;39:806-11.
Oei HHS, Vliegenthart R, Hofman A, Oudkerk M, Witteman JC. Risk factors for coronary calcification in older subjects. The Rotterdam Coronary Calcification Study. Eur Heart J 2004;25:48-55.
Oei HH, Vliegenthart R, Deckers JW, Hofman A, Oudkerk M, Witteman JC. The association of Rose questionnaire angina pectoris and coronary calcification in a general population: the Rotterdam calcification study. Ann Epidemiol 2004;14:431-6.
Ott A, Andersen K, Dewey ME, Letenneur L, Brayne C, Copeland JR, Dartigues JF, Kragh-Sorensen P, Lobo A, Martinez-Lage JM, Stijnen T, Hofman A, Launer LJ; EURODEM Incidence Research Group. Effect of smoking on global cognitive function in nondemented elderly. Neurology 2004;62:920-4.
Prins ND, Dijk EJ van, Heijer T den, Vermeer SE, Koudstaal PJ, Oudkerk M, Hofman A, Breteler MM. Cerebral white matter lesions and the risk of dementia. Arch Neurol 2004;61:1531-4.
Prins ND, Straaten ECW van, Dijk EJ van, Simoni M, Schijndel RA van, Vrooman HA, Koudstaal PJ, Scheltens P, Breteler MMB, Barkhof F. Measuring progression of cerebral white matter lesions on MRI: visual rating and volumetrics. Neurology 2004;62:1533-9.
Rietveld I, Janssen JA, Rossum EF van, Houwing-Duistermaat JJ, Rivadeneira F, Hofman A, Pols HA, Duijn CM van, Lamberts SW. A polymorphic CA repeat in the IGF-I gene is associated with gender-specific differences in body height, but has no effect on the secular trend in body height. Clin Endocrinol 2004;61:195-203.
Rivadeneira F, Houwing-Duistermaat JJ, Beck TJ, Janssen JA, Hofman A, Pols HA, Duijn CM van, Uitterlinden AG. The influence of an insulin-like growth factor I gene promoter polymorphism on hip bone geometry and the risk of nonvertebral fracture in the elderly: The Rotterdam Study. J Bone Miner Res 2004;19:1280-90.
Sayed-Tabatabaei FA, Schut AF, Hofman A, Bertoli-Avella AM, Vergeer J, Witteman JC, Duijn CM van. A study of gene-environment interaction on the gene for angiotensin converting enzyme: a combined functional and population based approach. J Med Genet 2004;41:99-103.
Schmidt R, Launer LJ, Nilsson LG, Pajak A, Sans S, Berger K, Breteler MM, Ridder M de, Dufouil C, Fuhrer R, Giampaoli S, Hofman A; CASCADE Consortium. Magnetic resonance imaging of the brain in diabetes.
Diabetes 2004;53:687-92.
Schoofs MW, Klift M van der, Hofman A, Duijn CM van, Stricker BH, Pols HA, Uitterlinden AG. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: The Rotterdam Study. J Bone Miner Res 2004;19:1490-6.
Schoofs MW, Sturkenboom MC, Klift M van der, Hofman A, Pols HA, Stricker BH. HMG-CoA reductase inhibitors and the risk of vertebral fracture. J Bone Miner Res 2004;19:1525-30. Schuit SC, Meurs JB van, Bergink AP, Klift M van der, Fang Y, Leusink G, Hofman A, Leeuwen JP van, Uitterlinden AG, Pols HA. Height in pre- and postmenopausal women is influenced by estrogen receptor alpha gene polymorphisms. J Clin Endocrinol Metab 2004;89:303-9.
Schuit SCE, Oei HHS, Witteman JCM, Geurts van Kessel CH, Meurs JBJ vam, Nijhuis RL, Leeuwen JPTM van, Jong FH de, Zillekens MC, Hofman A, Pols HAP, Uitterlinden AG. Estrogen receptor α gene polymorphisms and risk of myocardial infarction. JAMA 2004;291:2969-77.
Schuit SCE, Klift M van der, Weel AEAM, Laet CEDH de, Burger H, Seeman E, Hofman A, Uitterlinden AG, Leeuwen JPTM van, Pols HAP. Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study. Bone 2004;34:195-202.
Schut AFC, Sayed-Tabatabaei FA, Witteman JCM, Bertoli Avella AM, Vergeer JM, Pols HAP, Hofman A, Deinum J, Duijn CM van. Smoking-dependent effects on the angiotensin-converting enzyme gene insertion/deletion polymorphism on blood pressure. J Hypertension 2004;22:313-9.
Schut AF, Bleumink GS, Stricker BH, Hofman A, Witteman JC, Pols HA, Deckers JW, Deinum J, Duijn CM van. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects. Eur Heart J 2004;25:2143-8.
Slooter AJC, Cruts M, Hofman A, Koudstaal PJ, Kuip D van der, Ridder MAJ de, Witteman JCM, Breteler MMB, Broeckhoven C van, Duijn CM van. The impact of APOE on myocardial infraction, stroke, and dementia. The Rotterdam Study. Neurology 2004;62:1196-8.
Tiemeier H, Dijck W van, Hofman A, Witteman JCM, Stijnen T, Breteler MMB. Relationship between atherosclerosis and late-life depression. The Rotterdam Study. Arch Gen
Tomany SC, Wang JJ, Leeuwen R van, Klein R, Mitchell P, Jong PTVM de, Klein BEK, Vingerling JR, Smith W. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents.Ophthalmology 2004;137:750-2.
Visser LE, Penning-van Beest FJ, Wilson JH, Vulto AG, Kasbergen AA, Smet PA de, Hofman A, Stricker BH. Overanticoagulation associated with combined use of lactulose and coumarin anticoagulants. Br J Clin Pharmacol 2004;57:522-4.
Visser LE, Schaik RHN van, Vliet M van, Trienekens PH, Smet PAGM de, Vulto AG, Hofman A, Duijn CM van, Stricker BHCh. The risk of bleeding complications in patients with
cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Thromb Haemost 2004;92:61-6.
Visser LE, Vliet M van, Schaik RHN van, Kasbergen AAH, Smet PAGM de, Vulto AG, Hofman A, Duijn CM van, Stricker BHCh. The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. Pharmacogenetics 2004;14:27-33.
Visser LE, Bleumink GS, Trienekens PH, Vulto AG, Hofman A, Stricker BH. The risk of overanticoagulation in patients with heart failure on coumarin anticoagulants. Br J Haematol 2004;127:85-9.
Vliegenthart R, Oei HH, Elzen AP van den, Rooij FJ van, Hofman A, Oudkerk M, Witteman JC. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 2004;164:2355-60.
Vokó Z, Hollander M, Koudstaal PJ, Hofman A, Breteler MMB. How do American stroke risk functions perform in a Western European population? Neuroepidemiology 2004;23:247-53. Zhai G, Rivadeneira F, Houwing-Duistermaat JJ, Meulenbelt I, Bijkerk C, Hofman A, Meurs JBJ van, Uitterlinden AG, Pols HAP, Slagboom PE, Duijn CM van. Insulin-like growth factor I gene promoter polymorphism, collagen type IIα1 (COL2A1) gene, and the prevalence of radiographic osteoarthritis: the Rotterdam Study. Ann Rheum Dis 2004;63:544-8.
